Great study! 1️⃣ 686 sequences, ~13% of cases (‼️) 2️⃣ Evolutionary rate of 8.7×10-4 s/s/y (a little slow vs EBOV) 3️⃣ Doubling time: ~2 weeks 4️⃣ Timing: late February 2026 5️⃣ Slow start in in Mongbwalu, amplification in urban center(s) 6️⃣ No evidence of majority mutations linked to fitness increase 👏

“Quick power nap and then I’ll get to it”. Repeat.

Looking forward to it!

See you in Geneva!

Good question...

I really *do* hope your article will age better than the one it covered 😜.

Overall, though, I'm glad to see CREID (re)funded and hope that the centers - despite the shackles they have been put in - will be able to continue their impactful work. The new+old CREID centers all do great work across the spectrum of infectious disease research, so seeing them funded is great!

Further, the prior quote from HHS said ".. CREID money will go to people looking at infectious diseases in public health." Which, given the fact that technologies and tools we developed as part of CREID v1 are highly utilized by public health agencies, locally, nationally, and internationally, is 🤷‍♂️

... which is kinda funny because HHS specifically told Science "The CREID program will focus on emerging pathogens [..], such as Ebola virus and hantaviruses.." 😆🤷‍♂️

"... “We’re not funding Kristian Andersen and that virologist crew,” the [HHS] official was quoted as saying [...] Science has confirmed that Andersen’s team applied for continued CREID funding but did not get a new award." Indeed. With a specific focus on Ebola, Hantaviruses, Mpox, and Lassa.

Maybe the only real lesson from the Russian PUE case has been that authoritative sources- medias, scientists, even the WHO itself- are overly uncritical of, and influenced by, misinformation and conspiratorial thinking. there is a need for more info hygiene and empirical skepticism in biosecurity.

Oh, definitely all of them - except the latter 😆.